NO20003065L - Kombinasjon for effektiv behandling av impotens - Google Patents

Kombinasjon for effektiv behandling av impotens

Info

Publication number: NO20003065L
Authority: NO; Norway
Prior art keywords: impotence; combination; effective treatment; effective; treatment
Prior art date: 1997-12-16

Application number

NO20003065A

Other languages

English (en)

Other versions

NO20003065D0 (no

Inventor

Michael Grant Wyllie

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-16

Filing date

2000-06-15

Publication date

2000-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22090927&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003065(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-06-15 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-06-15 Publication of NO20003065D0 publication Critical patent/NO20003065D0/no

2000-08-15 Publication of NO20003065L publication Critical patent/NO20003065L/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

NO20003065A 1997-12-16 2000-06-15 Kombinasjon for effektiv behandling av impotens NO20003065L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6974197P	1997-12-16	1997-12-16
PCT/IB1998/001723 WO1999030697A2 (en)	1997-12-16	1998-10-29	Combination effective for the treatment of impotence

Publications (2)

Publication Number	Publication Date
NO20003065D0 NO20003065D0 (no)	2000-06-15
NO20003065L true NO20003065L (no)	2000-08-15

Family

ID=22090927

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20003065A NO20003065L (no)	1997-12-16	2000-06-15	Kombinasjon for effektiv behandling av impotens

Country Status (37)

Country	Link
EP (1)	EP1037616B1 (no)
JP (2)	JP2002508315A (no)
KR (1)	KR20010033092A (no)
CN (1)	CN1282248A (no)
AP (1)	AP915A (no)
AR (1)	AR016433A1 (no)
AT (1)	ATE318602T1 (no)
AU (1)	AU759825B2 (no)
BG (1)	BG104528A (no)
BR (1)	BR9813699A (no)
CA (1)	CA2314993A1 (no)
CO (1)	CO4810381A1 (no)
CZ (1)	CZ20002199A3 (no)
DE (1)	DE69833671T2 (no)
DZ (1)	DZ2675A1 (no)
EA (1)	EA200000526A1 (no)
ES (1)	ES2258300T3 (no)
GT (1)	GT199800177A (no)
HN (1)	HN1998000174A (no)
HR (1)	HRP20000407A2 (no)
HU (1)	HUP0100705A3 (no)
IL (1)	IL136515A0 (no)
IS (1)	IS5504A (no)
MA (1)	MA26586A1 (no)
NO (1)	NO20003065L (no)
NZ (1)	NZ504487A (no)
OA (1)	OA11423A (no)
PA (1)	PA8462801A1 (no)
PE (1)	PE20000011A1 (no)
PL (1)	PL341575A1 (no)
SK (1)	SK8782000A3 (no)
TN (1)	TNSN98227A1 (no)
TR (1)	TR200001733T2 (no)
UY (1)	UY25300A1 (no)
WO (1)	WO1999030697A2 (no)
YU (1)	YU33700A (no)
ZA (1)	ZA9811507B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6469065B1 (en)	1996-02-02	2002-10-22	Nitromed, Inc.	Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6331543B1 (en)	1996-11-01	2001-12-18	Nitromed, Inc.	Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
DE19844162A1 (de) *	1998-09-25	2000-03-30	Udo Dunzendorfer	Medikamentenkombinationen zur Therapie der erektilen Dysfunktion
CA2362918A1 (en) *	1999-03-08	2000-09-14	Elizabeth Stoner	Methods and compositions for treating erectile dysfunction
US7235625B2 (en) *	1999-06-29	2007-06-26	Palatin Technologies, Inc.	Multiple agent therapy for sexual dysfunction
AU4491200A (en) *	1999-08-03	2001-02-19	Lilly Icos Llc	Beta-carboline pharmaceutical compositions
TWI265925B (en)	1999-10-11	2006-11-11	Pfizer	Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
WO2002022127A1 (en) *	2000-09-13	2002-03-21	Isis Innovation Limited	Use of phosphodiesterase inhibitors for the treatment of anorectal disorders
IL155703A0 (en) *	2000-11-17	2003-11-23	Warner Lambert Co	Treatment of sexual dysfunction with non peptide bombesin receptor antagonists
US20030114469A1 (en) *	2001-09-27	2003-06-19	Cohen David Saul	Combinations
GB0219961D0 (en)	2002-08-28	2002-10-02	Pfizer Ltd	Oxytocin inhibitors
GB0225908D0 (en) *	2002-11-06	2002-12-11	Pfizer Ltd	Treatment of female sexual dysfunction
US7323462B2 (en)	2002-12-10	2008-01-29	Pfizer Inc.	Morpholine dopamine agonists
CA2451267A1 (en)	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
US7291640B2 (en)	2003-09-22	2007-11-06	Pfizer Inc.	Substituted triazole derivatives as oxytocin antagonists
AP2007004047A0 (en)	2005-01-20	2007-06-30	Pfizer Ltd	Substituted triazole derivatives as oxtocin antagonists
US8506934B2 (en)	2005-04-29	2013-08-13	Robert I. Henkin	Methods for detection of biological substances
BRPI0618643A2 (pt)	2005-11-09	2011-09-06	Combinatorx Inc	composição compreendendo um par de fármacos, composição compreendendo um corticosteróide e um imunossupressor dependente de imunofilina não-esteróide, kits e uso
US8293489B2 (en)	2007-01-31	2012-10-23	Henkin Robert I	Methods for detection of biological substances
US8580801B2 (en)	2008-07-23	2013-11-12	Robert I. Henkin	Phosphodiesterase inhibitor treatment
CN101781302B (zh) *	2009-05-31	2013-07-10	段波	一种磷酸二酯酶抑制剂和异黄酮形成的加成物及其应用
WO2013106547A1 (en)	2012-01-10	2013-07-18	President And Fellows Of Harvard College	Beta-cell replication promoting compounds and methods of their use
US20150297601A1 (en)	2012-10-05	2015-10-22	Robert I. Henkin	Phosphodiesterase inhibitor treatment
US10598672B2 (en)	2014-02-18	2020-03-24	Cyrano Therapeutics, Inc.	Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA878182B (en) *	1986-11-05	1988-05-02	Merrell Dow Pharmaceuticals Inc.	Enhancement of prazosin
FR2649613B1 (fr) *	1989-07-11	1991-09-27	Virag Ronald	Medicament vaso-actif
US5242391A (en) *	1990-04-25	1993-09-07	Alza Corporation	Urethral insert for treatment of erectile dysfunction
EP0459666B1 (en) *	1990-05-31	1994-11-09	Pfizer Inc.	Medicaments against impotence
GB9311920D0 (en) *	1993-06-09	1993-07-28	Pfizer Ltd	Therapeutic agents
GB9523752D0 (en) *	1995-11-21	1996-01-24	Pfizer Ltd	Pharmaceutical formulations

1998
- 1998-10-29 TR TR2000/01733T patent/TR200001733T2/xx unknown
- 1998-10-29 EP EP98947741A patent/EP1037616B1/en not_active Revoked
- 1998-10-29 BR BR9813699-2A patent/BR9813699A/pt not_active Application Discontinuation
- 1998-10-29 YU YU33700A patent/YU33700A/sh unknown
- 1998-10-29 KR KR1020007006455A patent/KR20010033092A/ko not_active Application Discontinuation
- 1998-10-29 PL PL98341575A patent/PL341575A1/xx unknown
- 1998-10-29 NZ NZ504487A patent/NZ504487A/xx unknown
- 1998-10-29 CN CN98812331A patent/CN1282248A/zh active Pending
- 1998-10-29 SK SK878-2000A patent/SK8782000A3/sk unknown
- 1998-10-29 CZ CZ20002199A patent/CZ20002199A3/cs unknown
- 1998-10-29 AU AU94558/98A patent/AU759825B2/en not_active Ceased
- 1998-10-29 JP JP2000538680A patent/JP2002508315A/ja active Pending
- 1998-10-29 CA CA002314993A patent/CA2314993A1/en not_active Abandoned
- 1998-10-29 IL IL13651598A patent/IL136515A0/xx unknown
- 1998-10-29 HU HU0100705A patent/HUP0100705A3/hu unknown
- 1998-10-29 AT AT98947741T patent/ATE318602T1/de not_active IP Right Cessation
- 1998-10-29 WO PCT/IB1998/001723 patent/WO1999030697A2/en active IP Right Grant
- 1998-10-29 DE DE69833671T patent/DE69833671T2/de not_active Expired - Fee Related
- 1998-10-29 EA EA200000526A patent/EA200000526A1/ru unknown
- 1998-10-29 ES ES98947741T patent/ES2258300T3/es not_active Expired - Lifetime
- 1998-11-09 GT GT199800177A patent/GT199800177A/es unknown
- 1998-11-10 PA PA19988462801A patent/PA8462801A1/es unknown
- 1998-11-11 HN HN1998000174A patent/HN1998000174A/es unknown
- 1998-11-30 CO CO98070722A patent/CO4810381A1/es unknown
- 1998-12-10 AP APAP/P/1998/001414A patent/AP915A/en active
- 1998-12-11 PE PE1998001206A patent/PE20000011A1/es not_active Application Discontinuation
- 1998-12-14 UY UY25300A patent/UY25300A1/es not_active Application Discontinuation
- 1998-12-15 MA MA25396A patent/MA26586A1/fr unknown
- 1998-12-15 AR ARP980106360A patent/AR016433A1/es unknown
- 1998-12-15 TN TNTNSN98227A patent/TNSN98227A1/fr unknown
- 1998-12-15 ZA ZA9811507A patent/ZA9811507B/xx unknown
- 1998-12-15 DZ DZ980285A patent/DZ2675A1/xx active
2000
- 2000-05-19 IS IS5504A patent/IS5504A/is unknown
- 2000-06-13 BG BG104528A patent/BG104528A/xx unknown
- 2000-06-15 OA OA1200000169A patent/OA11423A/en unknown
- 2000-06-15 NO NO20003065A patent/NO20003065L/no not_active Application Discontinuation
- 2000-06-16 HR HR20000407A patent/HRP20000407A2/hr not_active Application Discontinuation
2007
- 2007-08-20 JP JP2007213745A patent/JP2007332156A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
MA26586A1 (fr)	2004-12-20
PL341575A1 (en)	2001-04-23
CN1282248A (zh)	2001-01-31
CZ20002199A3 (cs)	2001-10-17
GT199800177A (es)	2000-05-02
DE69833671D1 (de)	2006-04-27
AP9801414A0 (en)	1998-12-31
PA8462801A1 (es)	2000-05-24
BR9813699A (pt)	2000-10-10
AR016433A1 (es)	2001-07-04
DZ2675A1 (fr)	2003-03-29
CO4810381A1 (es)	1999-06-30
SK8782000A3 (en)	2002-03-05
AU759825B2 (en)	2003-05-01
PE20000011A1 (es)	2000-01-18
TNSN98227A1 (fr)	2005-03-15
AU9455898A (en)	1999-07-05
EA200000526A1 (ru)	2000-12-25
AP915A (en)	2000-12-18
HUP0100705A3 (en)	2001-12-28
TR200001733T2 (tr)	2000-11-21
ES2258300T3 (es)	2006-08-16
IL136515A0 (en)	2001-06-14
HUP0100705A2 (hu)	2001-08-28
WO1999030697A2 (en)	1999-06-24
KR20010033092A (ko)	2001-04-25
HRP20000407A2 (en)	2000-10-31
NO20003065D0 (no)	2000-06-15
JP2007332156A (ja)	2007-12-27
UY25300A1 (es)	2000-12-29
EP1037616B1 (en)	2006-03-01
DE69833671T2 (de)	2006-11-30
ATE318602T1 (de)	2006-03-15
YU33700A (sh)	2004-05-12
JP2002508315A (ja)	2002-03-19
BG104528A (en)	2001-02-28
HN1998000174A (es)	1999-01-08
OA11423A (en)	2004-04-21
NZ504487A (en)	2002-11-26
EP1037616A2 (en)	2000-09-27
ZA9811507B (en)	2000-06-19
CA2314993A1 (en)	1999-06-24
WO1999030697A3 (en)	1999-08-26
IS5504A (is)	2000-05-19

Legal Events

Date	Code	Title	Description
2006-07-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20003065L (no)	2000-08-15	Kombinasjon for effektiv behandling av impotens
NO986052D0 (no)	1998-12-22	Antikonvulsive derivater for behandling av fedme
ATE235481T1 (de)	2003-04-15	Substituierte benzopyranderivate zur behandlung von entzündungen
DE69925306D1 (de)	2005-06-16	Behandlung von kohlenwasserstoffgas
NO974554L (no)	1998-07-15	FremgangsmÕte for behandling av en underjordisk formasjon
PT1032396E (pt)	2004-06-30	Esterilizacao de glucocorticoesteroides
ID24638A (id)	2000-07-27	Senyawa-senyawa anti aritmia bispidina
NO984431D0 (no)	1998-09-23	FremgangsmÕte for behandling av smerte
DE69807466D1 (de)	2002-10-02	Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
IS4789A (is)	1998-06-30	Meðferðarefnasambönd
NO996545D0 (no)	1999-12-29	Behandling av aluminiumslagg
DE69834937D1 (de)	2006-07-27	Antibiotika zur behandlung von magengeschwuren
DE69926485D1 (de)	2005-09-08	Behandlung von durchblasgasen
GB9723258D0 (en)	1998-01-07	Treatment of organic materials
NO982562D0 (no)	1998-06-04	Sammensetning for behandling av smerte
NO993549D0 (no)	1999-07-20	Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO20002481D0 (no)	2000-05-12	Kombinasjonsterapi for behandling av AIDS
NO20006383L (no)	2000-12-14	Fremgangsmåte for behandling
NO20000274D0 (no)	2000-01-19	Behandling av fluider
ID24439A (id)	2000-07-20	Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID17459A (id)	1998-01-08	Unsur-unsur pengobatan
ID24521A (id)	2000-07-20	Penggunaan tiazolidindion untuk pengobatan hiperglikemia
GB2324962B (en)	2001-10-03	Treatment of allergic conditions
NO942963D0 (no)	1994-08-10	Behandling av erektil dysfunksjon
ID29414A (id)	2001-08-30	Pengobatan depresi